To get insurance to cover weight loss medication, you generally need to confirm the drug is on your plan’s formulary, meet the clinical criteria your insurer sets (usually a qualifying BMI plus documented prior weight loss efforts), and have your prescribing doctor submit a complete prior authorization request. If the plan denies you, appeal. Patients who understand what insurers look for at each step, and who respond quickly to requests for more information, have significantly better odds of coming out with coverage.
Confirm the Drug Is on Your Plan’s Formulary
Start by pulling up your plan’s drug formulary and finding the exact medication your doctor wants to prescribe. Coverage varies dramatically from drug to drug. A plan may cover an older option like orlistat while excluding newer GLP-1 injectables such as Wegovy or Zepbound entirely. Semaglutide (Wegovy), tirzepatide (Zepbound), phentermine/topiramate (Qsymia), naltrexone/bupropion (Contrave), orlistat (Xenical), and liraglutide (Saxenda) are all FDA-approved for long-term weight management, but presence on that list has no bearing on whether your specific plan will pay.
Your plan’s Summary of Benefits and Coverage gives a high-level overview, and your insurer must make it available to you.1Centers for Medicare & Medicaid Services. Summary of Benefits and Coverage For real detail, look at the full formulary, which lists every covered drug by tier. A generic on a lower tier might carry a modest copay; a brand-name injectable on a specialty tier can carry 30% or higher coinsurance. At retail prices of $1,000 to $1,350 per month for GLP-1 injectables, even 30% coinsurance runs into hundreds of dollars per fill. Many plans also require you to meet your annual deductible before prescription coverage kicks in at all, which on a high-deductible plan can mean paying full price for months.
Meet the Clinical Criteria
Almost every insurer ties coverage to thresholds that mirror FDA labeling. The baseline is a body mass index of 30 or higher. Patients with a BMI between 27 and 30 can qualify too, but only with at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, cardiovascular disease, or obstructive sleep apnea.2Aetna. Weight Reduction Programs and Devices – Medical Clinical Policy Any qualifying condition needs to be clearly documented in your records with lab results, imaging, or specialist notes. An insurer reviewing a prior authorization does not take your word for it.
Step Therapy and Prior Attempts
Meeting the BMI and comorbidity criteria is not enough on its own. Most plans use step therapy protocols that require you to try and fail less costly treatments before they authorize an expensive drug. In practice that usually means documenting three to six months of a structured weight management program with dietary counseling, regular exercise, and sometimes a trial of a cheaper medication like orlistat or phentermine.2Aetna. Weight Reduction Programs and Devices – Medical Clinical Policy Your physician must record your participation, adherence, and results at each follow-up. Vague chart notes like “patient reports dieting” will not satisfy a reviewer.
Submit a Strong Prior Authorization
Prior authorization is where most coverage requests succeed or fail. Your prescribing doctor submits the request, and it needs to include your diagnosis, BMI history, comorbid conditions, and documentation of prior weight loss attempts. Insurers have standardized forms, and using the wrong or outdated version is one of the most common reasons for processing delays.
Standard decisions typically take 7 to 14 days. Expedited reviews for urgent medical situations can come back in as little as two business days.3Noridian Medicare. New Timeframe for Prior Authorization Decisions The insurer may come back requesting additional information, which resets the clock. If your doctor’s office is slow to respond, the authorization can lapse and the process starts over.
Treat the documentation package like a brief arguing medical necessity. The foundation is the physician’s clinical notes: your weight history over time (not a single BMI reading), any weight-related conditions with supporting lab work, and a clear statement of medical necessity explaining why medication is appropriate. Progress notes from the prior three to six months showing supervised weight loss efforts are typically required. Supporting records from a registered dietitian, endocrinologist, or cardiologist strengthen the case, because insurers look for consistency across the record. If primary care notes describe a structured program but no dietitian records back it up, the reviewer has a reason to doubt the claim. Submitting a complete package the first time matters, because resubmissions and appeals take months.
Why Requests Get Denied
The most common denial reasons are fixable. Administrative errors like wrong billing codes or misspelled patient names account for a significant share. After clerical mistakes, the next most frequent cause is insufficient documentation: no evidence that alternative treatments were tried, or no longitudinal BMI data showing the weight problem is chronic. A denial for “medical necessity not established” often means the paperwork did not tell the full story, not that the patient does not qualify.
Appeal a Denial
You have the right to appeal, and success rates on appeals are high enough that it is almost always worth doing. When your insurer denies coverage, it must send a written explanation with the specific reason and instructions for appealing.4Centers for Medicare & Medicaid Services. Has Your Health Insurer Denied Payment For a Medical Service? You Have a Right to Appeal Read that letter carefully. It tells you exactly what was missing, which is your roadmap for the appeal.
Internal Appeal
You have 180 days from the date you receive the denial to file an internal appeal.4Centers for Medicare & Medicaid Services. Has Your Health Insurer Denied Payment For a Medical Service? You Have a Right to Appeal A detailed letter from your prescribing physician that addresses the insurer’s stated reason for denial is the most important piece. If the denial cited insufficient documentation of prior treatment, include the missing records. If it cited medical necessity, your doctor should explain why this specific medication, and not a cheaper alternative, fits your clinical situation. Some insurers allow a peer-to-peer review, where your doctor speaks directly with the plan’s medical reviewer. These conversations can resolve misunderstandings quickly and are worth requesting if offered.
External Review
If the internal appeal fails, federal law requires your insurer to offer an external review by an independent third party.4Centers for Medicare & Medicaid Services. Has Your Health Insurer Denied Payment For a Medical Service? You Have a Right to Appeal You have four months from the internal appeal denial to request one. An independent review organization examines the case and issues a decision within 45 days for standard reviews, or 72 hours for urgent cases.5eCFR. 45 CFR 147.136 – Internal Claims and Appeals and External Review Processes The reviewer’s decision is legally binding. If they rule in your favor, the insurer must cover the medication. If you believe your insurer is handling your claim unfairly at any point, you can also file a complaint with your state insurance department.6National Association of Insurance Commissioners. Insurance Departments
Keep Coverage After Approval
Getting approved is only half the battle. Most insurers require periodic recertification, typically every six months, and they will pull coverage if you have not shown sufficient progress. The benchmark nearly every plan uses is a 5% reduction in body weight from your starting point before medication. Timelines vary slightly by drug: plans may expect that 5% loss within four months for liraglutide or naltrexone/bupropion, and within seven months for semaglutide or tirzepatide.7Excellus BCBS Provider. Weight-Related Comorbidities – Overweight, Obesity, and Cardiovascular Disease
After you clear that initial hurdle, ongoing recertification requires showing that you have maintained at least 5% weight loss or continued losing weight since the last review.7Excellus BCBS Provider. Weight-Related Comorbidities – Overweight, Obesity, and Cardiovascular Disease Some plans also track adherence, requiring proof that you are filling the prescription consistently. Miss a recertification deadline or fall short on progress, and the insurer can terminate coverage. You would then need to restart the authorization process from scratch. Keep every weigh-in documented, attend all follow-up appointments, and make sure your physician submits recertification paperwork before the deadline.
When Your Plan Excludes Weight Loss Drugs
Some plans do not just make coverage difficult; they exclude weight loss medications entirely. The type of plan you have determines what, if anything, you can do about it.
Marketplace Plans
ACA Marketplace plans rarely cover GLP-1 drugs prescribed solely for weight loss. A KFF analysis of federal plan data found only about 1% of Marketplace prescription drug plans covered Wegovy, compared to 82% that covered Ozempic, which contains the same active ingredient but is approved for diabetes.8KFF. Costly GLP-1 Drugs Are Rarely Covered for Weight Loss by Marketplace Plans The ACA does not require Marketplace plans to cover weight loss drugs, so most do not.
Self-Insured Employer Plans
If your employer self-insures its health plan, meaning the company pays claims directly rather than buying a policy, federal law gives the employer broad discretion over benefit design. Under ERISA, self-insured plans are exempt from state insurance mandates, including any state law that would otherwise require coverage of obesity treatment.9Office of the Law Revision Counsel. 29 USC 1144 – Other Laws Many large employers self-insure. Your plan document or Summary Plan Description will tell you whether that applies to you.
Medicare Part D
Medicare Part D excludes drugs used for weight loss by statute, permitting Part D plans to exclude “agents when used for anorexia, weight loss, or weight gain.”10Centers for Medicare & Medicaid Services. Part D Drugs/Part D Excluded Drugs A proposed rule would have changed this for 2026, but CMS did not finalize that provision.11Centers for Medicare & Medicaid Services. Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program Medicare Prescription Final Part D can still cover the same drugs when prescribed for a different FDA-approved indication, such as semaglutide for type 2 diabetes or cardiovascular risk reduction.12Office of the Assistant Secretary for Planning and Evaluation (ASPE). Medicare Coverage of Anti-Obesity Medications
Medicaid
State Medicaid programs must cover most FDA-approved drugs, but a statutory exception lets states decide whether to cover weight loss medications. Coverage for GLP-1 drugs prescribed for diabetes or cardiovascular disease is required; coverage for the same drugs prescribed for obesity alone is optional.13KFF. Medicaid Coverage of and Spending on GLP-1s Contact your state Medicaid office for current rules where you live.
Lower Out-of-Pocket Costs
Even with coverage, these drugs can be expensive. A few strategies help.
Manufacturer Savings Programs
Drug manufacturers offer copay savings cards that can sharply reduce costs for commercially insured patients. Novo Nordisk runs a program for Wegovy, and Eli Lilly runs one for Zepbound. These cards typically reduce a copay to a fixed amount per fill, sometimes as low as $25 for patients with qualifying commercial insurance. Patients on government insurance (Medicare, Medicaid, Tricare) generally cannot use them.
There is an important catch. Many insurers and pharmacy benefit managers now use copay accumulator programs that prevent manufacturer coupon payments from counting toward your deductible or out-of-pocket maximum. The card covers your share initially, but once its value runs out, you owe your full deductible as if you had never used it. More than 20 states have passed laws restricting these programs for state-regulated plans, but if your plan is self-insured under ERISA, those protections may not apply. Ask your insurer or benefits administrator directly whether your plan uses a copay accumulator before relying on a manufacturer card as a long-term cost strategy.
HSA and FSA Accounts
You can use a health savings account or flexible spending account to pay for weight loss medication, but only if the drug is prescribed to treat a specific disease diagnosed by a physician, such as obesity, diabetes, or heart disease. The IRS treats weight loss expenses the same as other medical expenses: they must be for diagnosis, treatment, or prevention of a disease, not for general health improvement.14IRS. Frequently Asked Questions About Medical Expenses Related to Nutrition, Wellness, and General Health Keep the written prescription and diagnosis documentation in case your account administrator asks for proof.
Switch Plans During Open Enrollment
If your current plan excludes weight loss drugs or places them on a prohibitively expensive tier, the most direct fix may be switching plans at your next open enrollment. Compare formularies before you enroll. For someone taking an expensive specialty medication, the formulary matters more than the premium. Employer plans sometimes change formulary coverage from year to year, so review the updated drug list even if you are staying with the same insurer. An insurance broker can help identify plans with better prescription drug coverage on the individual market.